Heme Oxygenase-1 (HMOX-1) and inhibitor of differentiation proteins (ID1, ID3) are key response mechanisms against iron-overload in pancreatic β-cells.


Journal

Molecular and cellular endocrinology
ISSN: 1872-8057
Titre abrégé: Mol Cell Endocrinol
Pays: Ireland
ID NLM: 7500844

Informations de publication

Date de publication:
01 12 2021
Historique:
received: 04 07 2021
revised: 08 09 2021
accepted: 16 09 2021
pubmed: 22 9 2021
medline: 30 3 2022
entrez: 21 9 2021
Statut: ppublish

Résumé

Iron overload promotes the generation of reactive oxygen species (ROS). Pancreatic β-cells can counter oxidative stress through multiple anti-oxidant responses. Herein, RNA-sequencing was used to describe the expression profile of iron regulatory genes in human islets with or without diabetes. Functional experiments including siRNA silencing, qPCR, western blotting, cell viability, ELISA and RNA-sequencing were performed as means of identifying the genetic signature of the protective response following iron overload-induced stress in human islets and INS-1. FTH1 and FTL genes were highly expressed in human islets and INS-1 cells, while hepcidin (HAMP) was low. FXN, DMT1 and FTHL1 genes were differentially expressed in diabetic islets compared to control. Silencing of Hamp in INS-1 cells impaired insulin secretion and influenced the expression of β-cell key genes. RNA-sequencing analysis in iron overloaded INS-1 cells identified Id1 and Id3 as the top down-regulated genes, while Hmox1 was the top upregulated. Expression of ID1, ID3 and HMOX1 was validated at the protein level in INS-1 cells and human islets. Differentially expressed genes (DEGs) were enriched for TGF-β, regulating stem cells, ferroptosis, and HIF-1 signaling. Hmox1-silenced cells treated with FAC elevated the expression of Id1 and Id3 expression than untreated cells. Our findings suggest that HMOX1, ID1 and ID3 define the response mechanism against iron-overload-induced stress in β-cells.

Identifiants

pubmed: 34547407
pii: S0303-7207(21)00306-3
doi: 10.1016/j.mce.2021.111462
pii:
doi:

Substances chimiques

FTL protein, human 0
HAMP protein, human 0
Hepcidins 0
ID1 protein, human 0
Inhibitor of Differentiation Protein 1 0
Inhibitor of Differentiation Proteins 0
Iron-Binding Proteins 0
Neoplasm Proteins 0
ID3 protein, human 147785-34-0
Ferritins 9007-73-2
Apoferritins 9013-31-4
FTH1 protein, human EC 1.-
Oxidoreductases EC 1.-
HMOX1 protein, human EC 1.14.14.18
Heme Oxygenase-1 EC 1.14.14.18

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

111462

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

Mawieh Hamad (M)

Department of Medical Lab. Sciences, College of Health Sciences, University of Sharjah, 27272, Sharjah, United Arab Emirates; Sharjah Institute for Medical Research, University of Sharjah, 27272, Sharjah, United Arab Emirates.

Abdul Khader Mohammed (AK)

Sharjah Institute for Medical Research, University of Sharjah, 27272, Sharjah, United Arab Emirates.

Mahmood Y Hachim (MY)

College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates.

Debasmita Mukhopadhy (D)

Sharjah Institute for Medical Research, University of Sharjah, 27272, Sharjah, United Arab Emirates.

Anila Khalique (A)

Sharjah Institute for Medical Research, University of Sharjah, 27272, Sharjah, United Arab Emirates.

Amina Laham (A)

Sharjah Institute for Medical Research, University of Sharjah, 27272, Sharjah, United Arab Emirates.

Sarah Dhaiban (S)

Sharjah Institute for Medical Research, University of Sharjah, 27272, Sharjah, United Arab Emirates.

Khuloud Bajbouj (K)

Sharjah Institute for Medical Research, University of Sharjah, 27272, Sharjah, United Arab Emirates.

Jalal Taneera (J)

Sharjah Institute for Medical Research, University of Sharjah, 27272, Sharjah, United Arab Emirates; Department of Basic Medical Sciences, College of Medicine, University of Sharjah, Sharjah, 27272, United Arab Emirates. Electronic address: jtaneera@sharjah.ac.ae.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH